BioLife Solutions reports Q3 results
- Co reports Q3 EPS of ($0.03) vs ($0.06) Capital IQ Consensus; revs +42.9% y/y to $3 mln vs $2.7 mln Capital IQ Consensus
- Co sees FY17 revenue of $10.8-11.0 mln versus $10.4 mln Capital IQ consensus
- Gross margin is expected to be between 60% and 62%; previous guidance for gross margin was a range of 58% to 62%.
- 2018 Preliminary Financial Guidance: Biopreservation media revenue is expected to range between $13.6 million to $14.7 million, representing growth of 25% to 35% over 2017.
No comments:
Post a Comment